Skip to main content

$4.40 0.06 (1.38%)

High

$4.46

Low

$4.23

Trades

1,020

Turnover

$2,463,536

Volume

565,229
30 June 2023 at 4:10pm
Register to track MYX and receive email alerts.
Subject
MYX Ann: Mayne Pharma adds generic ABSORICA to US portfolio

MYX Ann: Notification regarding unquoted securities - MYX

MYX Ann: Change of Director's Interest Notice

MYX Ann: 2021 Full Year Investor Presentation

MYX Ann: 2021 Full Year Media Release

MYX Ann: Appendix 4E and Statutory Accounts

MYX Ann: Mayne Pharma board renewal and new Chairman

MYX Ann: Class action proceeding

MYX Ann: Notification of cessation of securities - MYX

MYX Ann: Lapse of performance rights

MYX Ann: Change of Director's Interest Notice

MYX Ann: Mayne Pharma expands Australian dermatology portfolio

MYX Ann: NEXTSTELLIS oral contraceptive now available in the US

MYX Ann: NEXTSTELLIS FDA exclusivity & phase III data published

MYX Ann: Becoming a substantial holder

MYX Ann: Appendix 2A and Notice under ASX Listing Rule 3.10A

MYX Ann: Change in substantial holding

MYX Ann: FDA approval of novel oral contraceptive NEXTSTELLIS

MYX Ann: Appendix 3G

MYX Ann: New data on NEXTSTELLIS presented at ISSWSH conference

MYX Ann: Change in substantial holding

MYX Ann: 2021 Half Year Investor Presentation

MYX Ann: 2021 Half Year Media Release

MYX Ann: Half Yearly Report and Accounts

MYX Ann: Mayne Pharma launches Microgestin 24 FE tablets in the US

MYX Ann: Mayne Pharma successfully extends debt facility

MYX Ann: Change of Director's Interest Notice

MYX Ann: Appendix 3G

MYX Ann: 2020 AGM Results

MYX Ann: Chairman and CEO's Addresses to Shareholders

MYX Ann: Mayne Pharma Board Renewal

MYX Ann: New data on Mayne Pharma's TOLSURA presented at IDWeek 2020

MYX Ann: Lapse of rights and AGM Notice of Meeting clarification

Register to track MYX and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
NEU
PBP
RCE
SPL